NDC properties for NDC 9 72606-023
NDC item 72606002301
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-01 |
| NDC Item | 72606002301 |
| packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
NDC item 72606002302
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-02 |
| NDC Item | 72606002302 |
| packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-023-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
NDC item 72606002303
| NDC 9 | 72606-023 |
|---|---|
| NDC 10 | 72606-023-03 |
| NDC Item | 72606002303 |
| packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-023-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |